| Literature DB >> 31785614 |
Wanglin Li1, Boye Dong2, Baifu Peng3, Jiabao Lu3, Zixin Wu4, Guanwei Li4, Jie Cao5.
Abstract
PURPOSE: Glove single-port laparoscopy-assisted transanal total mesorectal excision (TaTME) has been successfully carried out in our medical center. The purpose of this study is to evaluate the feasibility of this emerging operation.Entities:
Keywords: Glove port; Rectal cancer; Single-port laparoscopic surgery; Transanal total mesorectal excision
Mesh:
Year: 2019 PMID: 31785614 PMCID: PMC6885307 DOI: 10.1186/s12957-019-1744-z
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Fig. 1Surgical approach. a The rectum was fully exposed with an anal retractor, then the tumor lesion location was confirmed and the level of incision in the lumen was accurately decided. b The rectal lumen was tightly occluded, and a full-thickness circumferential dissection was performed. c The glove single-port platform was constructed by the surgical gloves and trocars. d The specimen was extracted through the anus
Outcomes of glove single-port laparoscopy-assisted transanal total mesorectal excision
| Patient#1 | Patient#2 | Patient#3 | Patient#4 | Patient#5 | Mean ± SD | |
|---|---|---|---|---|---|---|
| Age (years) | 43 | 58 | 68 | 62 | 66 | 59.4 ± 9.94 |
| Gender | Female | Male | Male | Female | Male | – |
| Body mass index (kg/m2) | 19.5 | 23.5 | 23.2 | 25.2 | 24.6 | 23.2 ± 2.22 |
| ASA score | 1 | 1 | 2 | 2 | 1 | – |
| Underlying disease | No | No | HBP | No | No | – |
| Previous abdominal operation | No | No | No | No | No | – |
| Distance from anal verge (cm) | 5.0 | 6.0 | 4.0 | 5.0 | 4.0 | 4.8 ± 0.84 |
| Diameter of tumor (cm) | 1.5 | 3.0 | 2.0 | 2.5 | 2.0 | 2.2 ± 0.57 |
| Tumor position | Left lateral | Anterior | Posterior | Anterior | Anterior | – |
| Neoadjuvant therapy | Yes | No | No | No | No | – |
| Operative time (min) | 280 | 360 | 400 | 310 | 340 | 338.0 ± 46.04 |
| Estimated blood loss (ml) | 50 | 150 | 50 | 80 | 50 | 76.0 ± 43.46 |
| Length of specimen (cm) | 9.0 | 10.0 | 8.0 | 9.0 | 10.0 | 9.2 ± 0.84 |
| Lymph nodes harvested | 12 | 13 | 11 | 12 | 13 | 12.2 ± 0.84 |
| (y)TNM stage | yT1N0M0 | T3N1M0 | T1N0M0 | T2N0M0 | T2N1M0 | – |
| Circumferential margin | Negative | Negative | Negative | Negative | Negative | – |
| Bowel movement (days) | 3 | 2 | 3 | 4 | 3 | 3.0 ± 0.71 |
| LOS (days) | 8 | 7 | 9 | 10 | 9 | 8.6 ± 1.14 |
| Conversion | No | No | No | No | No | – |
| Reoperation | No | No | No | No | No | – |
| Complications | No | Stoma prolapse | No | No | No | – |
| 30-day readmission | No | No | No | No | No | – |
| Follow-up (months) | 17.0 | 16.0 | 14.0 | 15.0 | 12.0 | 14.8 ± 1.92 |
ASA American Society of Anesthesiologists, HBP high blood pressure, (y) TNM stage for patients that received neoadjuvant chemoradiotherapy, LOS length of hospital stay